Speaker

Rebecca Jackson

Associate Director, Global Development Systems, Johnson & Johnson Innovative Medicine

Rebecca Jackson, Associate Director, Global Development Systems at Johnson & Johnson Innovative Medicine, is speaking at Global Clinical Trials Connect 2027 (London, United Kingdom, 11–12 May 2027) in the session “EHR2 Sponsor Enablement – from Proof of Concept to Global Operational Scale”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

Global Clinical Trials Connect 2027
11–12 May 2027London, United Kingdom
- SpeakerEHR2 Sponsor Enablement – from Proof of Concept to Global Operational Scale
- PanelPanel Discussion: Shaping the Future of Medicine: The Pioneering Spirit of Clinical TrialsWith Nancy Meyerson-Hess, Diane Driver, Maria Palombini

More speakers at Global Clinical Trials Connect 2027

Dafni Glinos
Principal Data Scientist, Vertex Pharmaceuticals
Agata Krason
Senior Clinical Imaging Data Scientist, Roche
Karina Morley
Global Head Innovative Research & Strategic Alliances Biopharmaceutical Medical, AstraZeneca
Amer Alghabban
R&D Quality Regulatory Authority Inspection Management, Bristol Myers Squibb
Laura Risueno Ayerbe
Global Patient Affairs, Patient Engagement R&D, Servier
Tina Barton
Chief Operating Officer, eMQT

See all 30 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Rebecca Jackson, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].